Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q2 2023 Earnings Call Transcript

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q2 2023 Earnings Call Transcript August 10, 2023

Eton Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $0.15, expectations were $-0.09.

Operator: Good afternoon, and welcome to Eton Pharmaceuticals Second Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please be advised that this call is being recorded at the company’s request. At this time, I would like to turn it over to David Krempa, Chief Business Officer...